Tolerance Bio Inc., 2026-06-18
An SEC Form D private-offering notice from Philadelphia, PA, an undisclosed offering target in Biotech. Filed 2026-06-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biopharmaceutical company developing thymus based cell therapies aimed at restoring immune tolerance for autoimmune disease, transplant rejection and cancer, based in Philadelphia, Pennsylvania.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- TRAIL TETHER, INC., 2026-06-26, $1.5M, Easton, PA
- Emblok, Inc., 2026-06-18, $12M, Tampa, FL
- Athena Sports Holdings, LLC, 2026-06-24, $440K, Pittsburgh, PA
- Restora Medical, Inc., 2026-06-18, $7.4M, Irvine, CA
- Commonwealth Capital, LLC/PA, 2026-06-24, $2.5M, Haverford, PA
- Rejuvenate Bio Inc, 2026-06-18, $27M, San Diego, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.